WHO ARE WE?. Any personal information provided to us will be controlled by Remitly Europe Limited of 7th Floor, Xxxxxxx Two, Xxxxxxx Dock, Cork, X00 XX00, Ireland who is the data controller (Remitly, we, us or our).
WHO ARE WE?. Charterprime Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) to provide financial product advice, deal and make a market in foreign exchange contracts and derivatives to retail and wholesale clients. Charterprime Pty Ltd is the holder of an AFSL 421210.
WHO ARE WE?. Any personal information provided to us will be controlled by Remitly (DIFC) Limited of DIFC who is the data controller (Remitly, we, us or our).
WHO ARE WE?. 1.1. The App is operated by Wonde Limited which is a UK registered company in England and Wales under company number 08645640 and with its registered office address at Xxxxxxx House, 0 Xxxxx Xxxxx, Xxxxxxxxx, Xxxxxxx, Xxxxxxx, XX0 0XX.
WHO ARE WE?. PROTECT is a multi-national consortium of 34 public and private partners including academics, regulators, SMEs and EFPIA companies with extensive experience in pharmacovigilance. In orer to efficiently manage the PROTECT project, the research agenda was split into 7 sub-projects – work packages (WPs) which are complemented by a multi-layer management and governance structure including Consortium Assembly, Steering Committee and external expert group (External Advisory Board). Project coordination and management consists of (Deputy) Coordinator, PROTECT Management Support Team and Managing Entity of the IMI JU funding. The relationship between individual entities is shown in the diagram below. Managing Entity of IMI JU funding New tools for B/R integration & data collection representation Seven WPs are subdivided into six scientific (each addressing one of the objectives above) and one managerial packages which are distinct from one another by their specific objectives, their methodologies, the type of data they use and the required expertise, but complimentary with regard to the overall project. These WPs can be described as one WP concerned with the aspects of the organisation and management of PROTECT: WP1: Project management and administration four “vertical” WPs targeting the specific scientific objectives and methodological developments WP2: Framework for PE studies WP3: Methods for signal detection WP4: New methods for data collection from consumers WP5: Benefit-risk integration and representation two “horizontal” WPs concerned with the communication, validation and integration of the scientific work into an integrated and cohesive European activity WPco-L: FICF, Novartis Pharma WPco-L: PGRx (LASER), SARD Coordinator: EMA Deputy Coordinator: GSK Framework for PE studies Methods for signal detection New tools for data collection Benefit/risk integration and representation WP6: Validation studies involving an Extended Audience WP7: Training and communication Strengthen the monitoring of the safety of medicinal products Enhance the monitoring of the benefit-risk of medicines Better evaluate and communicate medicinal products’ benefit-risk profile throughout their lifecycle Develop modern ways of collecting data on medication, lifestyle and risk factors directly from consumers Enhance the early detection and assessment of adverse drug reactions
WHO ARE WE?. A. We are a 29-attorney law firm dedicated to conducting prompt, impartial, and thorough workplace and campus investigations. In each investigation, we implement a team approach with multiple levels of over sight. We tailor each investigation to the client’s needs, and offer a cost-effective approach through streamlined processes and flexible staffing options.
WHO ARE WE?. AxiCorp Financial Services Pty Ltd has authorised Corporate Authorised Representatives (which are Companies) and Authorised Representatives (who are Individuals) to provide financial services. As the licensee, AxiCorp is responsible for the service you receive from our representatives and us. CMG Australia Pty Ltd. is authorised, as well as its nominated representatives, by AxiCorp to provide the following financial services to retail and wholesale clients: ▪ deal in foreign exchange contracts and derivatives; ▪ provide financial product advice in relation to foreign exchange contracts and derivatives; To the extent that we authorise our representative to do so, your adviser can help you to apply for the financial products referred to the above and can also give you general financial product advice in relation to them. If your adviser is unable or unwilling to provide you with advice or services in respect of certain products, the adviser will refer you to another representative of AxiCorp, who should be able to assist you.
WHO ARE WE?. AxiCorp Financial Services Pty Ltd was established in 2008 to operate a foreign exchange business. It subsequently expanded its operations to include the issuing of other financial products that are the subject of our PDS, the delivery of services in respect of them and the development of platforms to facilitate the delivery of those services to Australian and international clients. AxiCorp is owned and supported by experienced and capable staff and investors which have provided the capital to expand and support its operations. AxiCorp is regulated by the New Zealand Financial Markets Authority (‘FMA’) in accordance with the Governing Legislation and is a Derivatives Issuer licence (‘DI Licence’) holder (FSP No. 518226) in respect of Transactions on financial markets.
WHO ARE WE?. AxiCorp Financial Services Pty Ltd was established in 2008 to operate a foreign exchange business. It subsequently expanded its operations to include the issuing of other financial products that are the subject of our PDS, the delivery of services in respect of them and the development of platforms to facilitate the delivery of those services to Australian and international clients. AxiCorp is owned and supported by experienced and capable staff and investors which have provided the capital to expand and support its operations. AxiCorp is the holder of an Australian Financial Services Licence No 000000, which authorises it to: • provide financial product advice; • deal and make a market in foreign exchange contracts; and • deal and make a market in derivatives to retail clients.
WHO ARE WE?. MEX Digital Pty Ltd is incorporated under the Corporations Act 2001 (Commonwealth) and is under the jurisdiction of the Australian Securities and Investments Commission (“ASIC”) and registered with the Australian Transactions Reports and Analysis Centre (“AUSTRAC”) to operate as a digital asset exchange; enabling clients to make purchase and sale orders on our Platform. The Firm is owned and supported by an experienced and capable staff and investors which have provided the capital to expand and support its operations.
